vs
Side-by-side financial comparison of Dexcom (DXCM) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× JBT Marel Corp). Dexcom runs the higher net margin — 21.2% vs 5.3%, a 16.0% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 21.6%). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
DXCM vs JBTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net Profit | $267.3M | $53.1M |
| Gross Margin | 62.9% | 34.5% |
| Operating Margin | 25.6% | 7.2% |
| Net Margin | 21.2% | 5.3% |
| Revenue YoY | 21.6% | 115.6% |
| Net Profit YoY | 153.6% | 858.6% |
| EPS (diluted) | $0.67 | $1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $934.8M | ||
| Q1 25 | $1.0B | $854.1M | ||
| Q4 24 | $1.1B | $467.6M | ||
| Q3 24 | $994.2M | $453.8M | ||
| Q2 24 | $1.0B | $402.3M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $53.1M | ||
| Q3 25 | $283.8M | $66.0M | ||
| Q2 25 | $179.8M | $3.4M | ||
| Q1 25 | $105.4M | $-173.0M | ||
| Q4 24 | $151.7M | $-7.0M | ||
| Q3 24 | $134.6M | $38.9M | ||
| Q2 24 | $143.5M | $30.7M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 34.5% | ||
| Q3 25 | 60.5% | 35.9% | ||
| Q2 25 | 59.5% | 35.8% | ||
| Q1 25 | 56.9% | 34.2% | ||
| Q4 24 | 58.9% | 38.4% | ||
| Q3 24 | 59.7% | 36.1% | ||
| Q2 24 | 62.4% | 35.6% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 7.2% | ||
| Q3 25 | 20.1% | 10.2% | ||
| Q2 25 | 18.4% | 5.2% | ||
| Q1 25 | 12.9% | -3.9% | ||
| Q4 24 | 17.0% | 3.4% | ||
| Q3 24 | 15.3% | 10.3% | ||
| Q2 24 | 15.7% | 6.7% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 5.3% | ||
| Q3 25 | 23.5% | 6.6% | ||
| Q2 25 | 15.5% | 0.4% | ||
| Q1 25 | 10.2% | -20.3% | ||
| Q4 24 | 13.6% | -1.5% | ||
| Q3 24 | 13.5% | 8.6% | ||
| Q2 24 | 14.3% | 7.6% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.04 | ||
| Q3 25 | $0.70 | $1.26 | ||
| Q2 25 | $0.45 | $0.07 | ||
| Q1 25 | $0.27 | $-3.35 | ||
| Q4 24 | $0.37 | $-0.22 | ||
| Q3 24 | $0.34 | $1.21 | ||
| Q2 24 | $0.35 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $167.9M |
| Total DebtLower is stronger | — | $1.5B |
| Stockholders' EquityBook value | $2.7B | $4.5B |
| Total Assets | $6.3B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $167.9M | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | $1.2B | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $648.3M | ||
| Q2 24 | — | $647.7M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.5B | ||
| Q3 25 | $2.7B | $4.4B | ||
| Q2 25 | $2.6B | $4.4B | ||
| Q1 25 | $2.3B | $4.1B | ||
| Q4 24 | $2.1B | $1.5B | ||
| Q3 24 | $2.0B | $1.6B | ||
| Q2 24 | $2.4B | $1.5B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $8.2B | ||
| Q3 25 | $7.5B | $8.2B | ||
| Q2 25 | $7.3B | $8.3B | ||
| Q1 25 | $6.8B | $8.0B | ||
| Q4 24 | $6.5B | $3.4B | ||
| Q3 24 | $6.4B | $2.8B | ||
| Q2 24 | $6.8B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $117.4M |
| Free Cash FlowOCF − Capex | — | $83.5M |
| FCF MarginFCF / Revenue | — | 8.3% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | — | 2.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $117.4M | ||
| Q3 25 | $659.9M | $87.7M | ||
| Q2 25 | $303.0M | $102.2M | ||
| Q1 25 | $183.8M | $34.4M | ||
| Q4 24 | $301.4M | $128.7M | ||
| Q3 24 | $199.5M | $71.9M | ||
| Q2 24 | $279.4M | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $83.5M | ||
| Q3 25 | $579.4M | $56.5M | ||
| Q2 25 | $208.9M | $83.7M | ||
| Q1 25 | $96.8M | $14.4M | ||
| Q4 24 | $176.8M | $118.7M | ||
| Q3 24 | $88.3M | $65.0M | ||
| Q2 24 | $213.3M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 8.3% | ||
| Q3 25 | 47.9% | 5.6% | ||
| Q2 25 | 18.1% | 9.0% | ||
| Q1 25 | 9.3% | 1.7% | ||
| Q4 24 | 15.9% | 25.4% | ||
| Q3 24 | 8.9% | 14.3% | ||
| Q2 24 | 21.2% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 3.4% | ||
| Q3 25 | 6.7% | 3.1% | ||
| Q2 25 | 8.1% | 2.0% | ||
| Q1 25 | 8.4% | 2.3% | ||
| Q4 24 | 11.2% | 2.1% | ||
| Q3 24 | 11.2% | 1.5% | ||
| Q2 24 | 6.6% | 2.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 2.21× | ||
| Q3 25 | 2.33× | 1.33× | ||
| Q2 25 | 1.69× | 30.06× | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 1.85× | ||
| Q2 24 | 1.95× | 0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
